Ernexa Therapeutics (ERNAW) Depreciation & Amortization - Total (2017 - 2018)
Ernexa Therapeutics (ERNAW) reported Depreciation & Amortization - Total of $2.4 million for Q4 2018, up 15.98% on a YoY basis from $2.0 million in Q4 2017, and up 15.98% quarter-over-quarter from $2.0 million in Q4 2017.
Ernexa Therapeutics (ERNAW) Depreciation & Amortization - Total (2017 - 2018) Analysis & Trends
Ernexa Therapeutics has reported Depreciation & Amortization - Total for 2 years, with the latest figure at $2.4 million in Q4 2018.
- For the quarter ending Q4 2018, Depreciation & Amortization - Total rose 15.98% year-over-year to $2.4 million; the trailing twelve-month figure through Sep 2019 stood at $2.4 million (up 15.98% YoY), and the FY2020 full-year result was $1.2 million, down 49.62% from the prior year.
- Depreciation & Amortization - Total for Q4 2018 stood at $2.4 million, up from $2.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was $2.4 million in Q4 2018, with the low at $2.0 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2.35 Mn |
| Dec 31, 2017 | 2.03 Mn |